17
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Single-Dose Granulocyte Colony-Stimulating Factor Concomitant with Multifractionated Dose Chemotherapy: A Strategy for Maintaining Dose Intensity

OP-ED

Pages 547-550 | Published online: 11 Jun 2009

References

  • American Society of Clinical Oncology. Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. J Clin Oncol 1996; 14: 1957–1960
  • Livingston R B, Ellis G K, Gralow J R. Dose-intensive vinorel-bine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 1997; 15: 1395–1400
  • Lokich J, Anderson N, Bern M. Paclitaxel, cisplatin, etoposide combination chemotherapy: a comparison of dose intensity in two multifractionated dose schemes. Eur J Cancer 1998; 34: 664–667
  • Lokich J, Anderson N, Bern M. Phase I—II study of multi-fractionated combination chemotherapy for advanced non-small cell lung cancer; taxol, platinol, navelbine (TPN). Cancer 1999; 85: 499–503
  • Lokich J. Multifractionated dosing for cancer chemotherapy: a novel schedule and a work in progress. Cancer Invest 1999; 17: 551–554

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.